Correction:Translational Neurodegeneration(2022)11:37 https://***/10.1186/s40035-022-00311-3 In the original publication of this article[1],“AN”is miss-ing in the column heading“Patients underwent NS at the(n=46)”...
详细信息
Correction:Translational Neurodegeneration(2022)11:37 https://***/10.1186/s40035-022-00311-3 In the original publication of this article[1],“AN”is miss-ing in the column heading“Patients underwent NS at the(n=46)”in Table 1 due to a typesetting *** correct column heading should be“Patients underwent NS at the AN(n=46)”.Moreover,the asterisk symbol*in“27(84)*”and“5(45)*”should be *** addition,the phrase“using FLOQBrushes(Copan Italia,Brescia,Italy)”needs be added in the first sentence under the header“OM sample collection”of the Methods section.
A survey report was conducted among 12 Italian centres experi-enced in fine-needle biopsy of the *** questions concerned:*** per-formance of inpatient or outpatient fine-needle biopsy;*** policy of routinehemostatic e...
详细信息
A survey report was conducted among 12 Italian centres experi-enced in fine-needle biopsy of the *** questions concerned:*** per-formance of inpatient or outpatient fine-needle biopsy;*** policy of routinehemostatic evaluation;*** management of patients taking aspirin;*** of biopsies performed and the diagnoses obtained;*** complicationsthat occurred in relation to coagulation tests *** results were as follows:1.10 out of 12 centres performed biopsiesmainly on outpatients;*** only 2 of the 12 centres was a history investigatingthe patient’s hemostasis collected;all centres routinely performed coagulationtests;the most frequent combination included prothrombin time,partialthromboplastin time and platelet *** the centres a great variabilityconcerning the test values considered safe existed;*** 10 of the 12 centresbiopsy was not deferred if the patient was taking aspirin;*** amount ofbiopsies performed was 9156 on a total of 6261 patients,mainly in diagnosingmalignant focal liver lesions;*** 2 out of 6261 patients(0.03%)bleedingcomplications were fatal and in 8 out of 6261(0.13%)non-fatal but *** hemostatic decompensation,factors involved in the risk of post-biopsybleeding were the type of the lesion(malignant or hemangiomatous)and the co-existence of cirrhosis.
暂无评论